Comparar métodos
Revisa los métodos seleccionados uno junto a otro; las filas que difieren aparecen resaltadas.
| Estudio epidemiológico transversal× | Evaluación de Pruebas de Cribado× | |
|---|---|---|
| Campo | Epidemiología | Epidemiología |
| Familia | Process / pipeline | Process / pipeline |
| Año de origen≠ | 1960s (formal codification); widely practiced since mid-20th century | 1968 (Wilson-Jungner principles); statistical framework developed 1970s–2000s |
| Autor original≠ | Classical epidemiology tradition; systematized by Brian MacMahon and Thomas Pugh (1960s) | Wilson & Jungner (WHO criteria, 1968); foundational work by Pepe, Altman, and others in statistical test evaluation |
| Tipo≠ | Observational, descriptive/analytic epidemiological design | Observational diagnostic / epidemiological evaluation design |
| Fuente seminal≠ | Kelsey, J. L., Whittemore, A. S., Evans, A. S., & Thompson, W. D. (1996). Methods in Observational Epidemiology (2nd ed.). Oxford University Press. ISBN: 978-0195080407 | Wilson, J. M. G., & Jungner, G. (1968). Principles and Practice of Screening for Disease. World Health Organization. Public Health Papers No. 34. link ↗ |
| Alias | prevalence study, cross-sectional survey, transversal study, cross-sectional design | screening study, screening performance evaluation, screening accuracy assessment, STE |
| Relacionados | 6 | 6 |
| Resumen≠ | A cross-sectional epidemiological study measures the exposure(s) and outcome(s) of interest simultaneously in a defined population at a single point in time (or over a short period). Because there is no follow-up, it is the most efficient observational design for estimating disease prevalence and for generating hypotheses about associations between risk factors and health outcomes. | Screening test evaluation is a systematic epidemiological approach for assessing whether a test or program can accurately and cost-effectively identify individuals with a condition before symptoms appear. It quantifies diagnostic performance metrics — sensitivity, specificity, predictive values, and the ROC curve — and evaluates whether a screening program meets established public health criteria for adoption and harm-benefit balance. |
| ScholarGateConjunto de datos ↗ |
|
|